Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
Int J Oncol
    April 2021
  1. OUYANG J, Xie Z, Lei X, Tang G, et al
    Clinical crosstalk between microRNAs and gastric cancer (Review).
    Int J Oncol. 2021;58:1.
    >> Share

    January 2021
  2. BALI P, Lozano-Pope I, Pachow C, Obonyo M, et al
    Early detection of tumor cells in bone marrow and peripheral blood in a fastprogressing gastric cancer model.
    Int J Oncol. 2021 Jan 12. doi: 10.3892/ijo.2021.5171.
    >> Share

    September 2020
  3. FENG J, Xiao T, Lu SS, Hung XP, et al
    ANXA1derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Int J Oncol. 2020 Sep 7. doi: 10.3892/ijo.2020.5119.
    >> Share

  4. SUN Z, Gao X, Zabkiewicz C, Ruge F, et al
    Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
    Int J Oncol. 2020;57:813-824.
    >> Share

    May 2020
  5. XU X, Xia Y, Ma J, Li W, et al
    Upregulation of miRNA301a3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NFkappaB signaling.
    Int J Oncol. 2020 May 26. doi: 10.3892/ijo.2020.5072.
    >> Share

    April 2020
  6. LIU AG, Zhong JC, Chen G, He RQ, et al
    Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
    Int J Oncol. 2020 Apr 15. doi: 10.3892/ijo.2020.5048.
    >> Share

  7. YAMAKOSHI Y, Tanaka H, Sakimura C, Deguchi S, et al
    Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
    Int J Oncol. 2020 Apr 8. doi: 10.3892/ijo.2020.5042.
    >> Share

    February 2020
  8. LONG B, Qin L, Zhang B, Li Q, et al
    CAR Tcell therapy for gastric cancer: Potential and perspective (Review).
    Int J Oncol. 2020 Feb 12. doi: 10.3892/ijo.2020.4982.
    >> Share

    December 2019
  9. SUN T, Wang D, Ping Y, Sang Y, et al
    Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Int J Oncol. 2019 Dec 16. doi: 10.3892/ijo.2019.4944.
    >> Share

    November 2019
  10. SZATANEK R, Weglarczyk K, Stec M, Baran J, et al
    Autologous tumorderived microvesicles influence gene expression profiles and enhance protumorigenic chemotactic potential, signal transduction and cellular respiration in gastric cancer cells.
    Int J Oncol. 2019 Nov 26. doi: 10.3892/ijo.2019.4923.
    >> Share

    September 2019
  11. LI H, Wang C, Wei Z, Chen W, et al
    Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
    Int J Oncol. 2019 Sep 26. doi: 10.3892/ijo.2019.4885.
    >> Share

    August 2019
  12. SHIOZAKI A, Yamazato Y, Kosuga T, Kudou M, et al
    Effect of low temperature on the regulation of cell volume after hypotonic shock in gastric cancer cells.
    Int J Oncol. 2019 Aug 2. doi: 10.3892/ijo.2019.4853.
    >> Share

    July 2019
  13. LI J, Xi H, Guo X, Gao Y, et al
    Surgical outcomes and learning curve analysis of robotic gastrectomy for gastric cancer: Multidimensional analysis compared with threedimensional highdefinition laparoscopic gastrectomy.
    Int J Oncol. 2019 Jul 30. doi: 10.3892/ijo.2019.4851.
    >> Share

  14. ALARCON-MILLAN J, Martinez-Carrillo DN, Peralta-Zaragoza O, Fernandez-Tilapa G, et al
    Regulation of GKN1 expression in gastric carcinogenesis: A problem to resolve (Review).
    Int J Oncol. 2019 Jul 16. doi: 10.3892/ijo.2019.4843.
    >> Share

    June 2019
  15. DENG LM, Tan T, Zhang TY, Xiao XF, et al
    miR1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
    Int J Oncol. 2019 Jun 25. doi: 10.3892/ijo.2019.4831.
    >> Share

  16. WANG W, Liu L, Zhou Y, Ye Q, et al
    Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer.
    Int J Oncol. 2019 Jun 12. doi: 10.3892/ijo.2019.4824.
    >> Share

  17. GAN L, Lv L, Liao S
    Long noncoding RNA H19 regulates cell growth and metastasis via the miR223p/Snail1 axis in gastric cancer.
    Int J Oncol. 2019;54:2157-2168.
    >> Share

  18. WANG J, Yao Y, Zhang Q, Li S, et al
    Inflammatory responses induced by Helicobacter pylori on the carcinogenesis of gastric epithelial GES1 cells.
    Int J Oncol. 2019;54:2200-2210.
    >> Share

    April 2019
  19. LU CC, Chiang JH, Tsai FJ, Hsu YM, et al
    Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.
    Int J Oncol. 2019;54:1271-1281.
    >> Share

    March 2019
  20. ZHI X, Li B, Li Z, Zhang J, et al
    Adrenergic modulation of AMPKdependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer.
    Int J Oncol. 2019 Mar 18. doi: 10.3892/ijo.2019.4753.
    >> Share

  21. CHEN C, Tang X, Liu Y, Zhu J, et al
    Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Int J Oncol. 2019 Mar 18. doi: 10.3892/ijo.2019.4751.
    >> Share

  22. FU R, Wang X, Hu Y, Du H, et al
    Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
    Int J Oncol. 2019 Mar 12. doi: 10.3892/ijo.2019.4744.
    >> Share

    February 2019
  23. LI J, Feng D, Gao C, Zhang Y, et al
    Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4728.
    >> Share

  24. AN C, Li H, Zhang X, Wang J, et al
    Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.
    Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4717.
    >> Share

    January 2019
  25. WANG S, Yao Y, Rao C, Zheng G, et al
    25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-kappaB signaling pathway.
    Int J Oncol. 2019 Jan 11. doi: 10.3892/ijo.2019.4684.
    >> Share

  26. JIAO Y, Yang H, Qian J, Gong Y, et al
    miR36645P suppresses the proliferation and metastasis of gastric cancer by attenuating the NFkappaB signaling pathway through targeting MTDH.
    Int J Oncol. 2019 Jan 8. doi: 10.3892/ijo.2019.4680.
    >> Share

  27. SHU F, Zou X, Tuo H, She S, et al
    Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.
    Int J Oncol. 2019 Jan 3. doi: 10.3892/ijo.2019.4674.
    >> Share

    December 2018
  28. HUANG L, Wang ZY, Pan DD
    Penicillinbinding protein 1A mutationpositive Helicobacter pylori promotes epithelialmesenchymal transition in gastric cancer via the suppression of microRNA134.
    Int J Oncol. 2018 Dec 12. doi: 10.3892/ijo.2018.4665.
    >> Share

    November 2018
  29. MA C, Xie J, Luo C, Yin H, et al
    OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGFC expression and secretion.
    Int J Oncol. 2018 Nov 26. doi: 10.3892/ijo.2018.4648.
    >> Share

  30. FANG Z, Zhong M, Wang Y, Yuan X, et al
    miR381 and miR489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/betacatenin pathway in gastric cancer.
    Int J Oncol. 2018 Nov 26. doi: 10.3892/ijo.2018.4646.
    >> Share

  31. SONG Y, Wang R, Li LW, Liu X, et al
    Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer.
    Int J Oncol. 2018 Nov 5. doi: 10.3892/ijo.2018.4625.
    >> Share

  32. LIU F, Cheng L, Xu J, Guo F, et al
    miR-17-92 functions as an oncogene and modulates NF-kappaB signaling by targeting TRAF3 in MGC-803 human gastric cancer cells.
    Int J Oncol. 2018;53:2241-2257.
    >> Share

  33. NGABIRE D, Seong YA, Patil MP, Niyonizigiye I, et al
    Induction of apoptosis and G1 phase cell cycle arrest by Aster incisus in AGS gastric adenocarcinoma cells.
    Int J Oncol. 2018;53:2300-2308.
    >> Share

    October 2018
  34. YAN L, Zhang J, Guo D, Ma J, et al
    IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Int J Oncol. 2018 Oct 31. doi: 10.3892/ijo.2018.4612.
    >> Share

  35. XI Z, Si J, Nan J
    LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer.
    Int J Oncol. 2018 Oct 26. doi: 10.3892/ijo.2018.4609.
    >> Share

  36. WANG M, Qiu R, Yu S, Xu X, et al
    Paclitaxelresistant gastric cancer MGC803 cells promote epithelialtomesenchymal transition and chemoresistance in paclitaxelsensitive cells via exosomal delivery of miR1555p.
    Int J Oncol. 2018 Oct 22. doi: 10.3892/ijo.2018.4601.
    >> Share

  37. YAN R, Li K, Yuan DW, Wang HN, et al
    Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Int J Oncol. 2018 Oct 12. doi: 10.3892/ijo.2018.4595.
    >> Share

  38. HUANG H, Tang J, Zhang L, Bu Y, et al
    miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.
    Int J Oncol. 2018 Oct 11. doi: 10.3892/ijo.2018.4593.
    >> Share

    September 2018
  39. CHUA PJ, Lim JP, Guo TT, Khanna P, et al
    Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells.
    Int J Oncol. 2018 Sep 11. doi: 10.3892/ijo.2018.4557.
    >> Share

    August 2018
  40. CAO B, Zhao Y, Zhang Z, Li H, et al
    Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.
    Int J Oncol. 2018 Aug 9. doi: 10.3892/ijo.2018.4519.
    >> Share

    June 2018
  41. LI L, Cui Y, Ye L, Zhao Z, et al
    Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Int J Oncol. 2018 Jun 26. doi: 10.3892/ijo.2018.4455.
    >> Share

  42. PEI L, He X, Li S, Sun R, et al
    KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4446.
    >> Share

  43. HU C, Zhou Y, Liu C, Kang Y, et al
    A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4433.
    >> Share

    May 2018
  44. OKUGAWA Y, Toiyama Y, Ichikawa T, Kawamura M, et al
    Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4406.
    >> Share

    April 2018
  45. WANG J, Liang WJ, Min GT, Wang HP, et al
    LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4356.
    >> Share

    March 2018
  46. YU S, Li L, Wu Q, Dou N, et al
    PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4329.
    >> Share

    February 2018
  47. ZHOU D, Zhou Y, Li C, Yang L, et al
    Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.
    Int J Oncol. 2018 Feb 13. doi: 10.3892/ijo.2018.4274.
    >> Share

  48. LU M, Huang Y, Sun W, Li P, et al
    miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
    Int J Oncol. 2018;52:589-598.
    >> Share

  49. LI L, Yang D, Cui D, Li Y, et al
    Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.
    Int J Oncol. 2018;52:473-484.
    >> Share

    January 2018
  50. LIAN G, Li L, Shi Y, Jing C, et al
    BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Int J Oncol. 2018 Jan 25. doi: 10.3892/ijo.2018.4255.
    >> Share

  51. FEI HJ, Chen SC, Zhang JY, Li SY, et al
    Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
    Int J Oncol. 2018 Jan 11. doi: 10.3892/ijo.2018.4243.
    >> Share

  52. ARAI H, Wada R, Ishino K, Kudo M, et al
    Expression of DNA damage response proteins in gastric cancer: Comprehensive protein profiling and histological analysis.
    Int J Oncol. 2018 Jan 5. doi: 10.3892/ijo.2018.4238.
    >> Share

    December 2017
  53. YAN H, Xiao F, Zou J, Qiu C, et al
    NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFalpha-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy.
    Int J Oncol. 2017 Dec 4. doi: 10.3892/ijo.2017.4216.
    >> Share

    October 2017
  54. WANG YM, Gu ML, Meng FS, Jiao WR, et al
    Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.
    Int J Oncol. 2017 Oct 23. doi: 10.3892/ijo.2017.4176.
    >> Share

  55. LIU Y, Zhang C, Zhao L, Du N, et al
    APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
    Int J Oncol. 2017;51:1343-1351.
    >> Share

  56. ZHOU J, Wu X, Li G, Gao X, et al
    Prediction of radiosensitive patients with gastric cancer by developing gene signature.
    Int J Oncol. 2017;51:1067-1076.
    >> Share

    September 2017
  57. WANG G, Huang YX, Zhang R, Hou LD, et al
    Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC7901 cells partly via miR200amediated downregulation of beta-catenin pathway.
    Int J Oncol. 2017 Sep 27. doi: 10.3892/ijo.2017.4139.
    >> Share

  58. WEI F, Jiang X, Gao HY, Gao SH, et al
    Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo.
    Int J Oncol. 2017 Sep 22. doi: 10.3892/ijo.2017.4134.
    >> Share

    August 2017
  59. PAN Z, Tian Y, Zhang B, Zhang X, et al
    YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
    Int J Oncol. 2017 Aug 23. doi: 10.3892/ijo.2017.4101.
    >> Share

    July 2017
  60. LEE H, Saini N, Parris AB, Zhao M, et al
    Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Int J Oncol. 2017 Jul 13. doi: 10.3892/ijo.2017.4073.
    >> Share

  61. XU M, Qin S, Cao F, Ding S, et al
    MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Int J Oncol. 2017 Jul 12. doi: 10.3892/ijo.2017.4072.
    >> Share

    May 2017
  62. KIM B, Kim YS, Ahn HM, Lee HJ, et al
    Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer.
    Int J Oncol. 2017 May 19. doi: 10.3892/ijo.2017.4013.
    >> Share

  63. DU Y, Jiang B, Song S, Pei G, et al
    Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4002.
    >> Share

  64. XIAO S, Zhou L
    Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.4000.
    >> Share

  65. GE L, Li DS, Chen F, Feng JD, et al
    TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3998.
    >> Share

  66. ZHUANG K, Zhang L, Zhang X, Tang H, et al
    Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
    Int J Oncol. 2017 May 4. doi: 10.3892/ijo.2017.3983.
    >> Share

  67. ZENG XQ, Wang J, Chen SY
    Methylation modification in gastric cancer and approaches to targeted epigenetic therapy (Review).
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3981.
    >> Share

  68. FUJIWARA Y, Okada K, Omori T, Sugimura K, et al
    Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
    Int J Oncol. 2017;50:1655-1662.
    >> Share

    April 2017
  69. PAN Y, Shu X, Sun L, Yu L, et al
    miR196a5p modulates gastric cancer stem cell characteristics by targeting Smad4.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3965.
    >> Share

  70. WANG R, Song Y, Liu X, Wang Q, et al
    UBE2C induces EMT through Wnt/betacatenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Int J Oncol. 2017;50:1116-1126.
    >> Share

    March 2017
  71. HUANG T, Wang L, Liu D, Li P, et al
    FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
    Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3927.
    >> Share

  72. WANG C, Yang C, Ji J, Jiang J, et al
    Deubiquitinating enzyme USP20 is a positive regulator of Claspin and suppresses the malignant characteristics of gastric cancer cells.
    Int J Oncol. 2017 Mar 8. doi: 10.3892/ijo.2017.3904.
    >> Share

  73. NASSER MI, Masood M, Wei W, Li X, et al
    Cordycepin induces apoptosis in SGC7901 cells through mitochondrial extrinsic phosphorylation of PI3K/Akt by generating ROS.
    Int J Oncol. 2017;50:911-919.
    >> Share

    February 2017
  74. SHEN L, Luo Z, Wu J, Qiu L, et al
    Enhanced expression of alpha2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3882.
    >> Share

  75. FUJIMOTO D, Goi T, Hirono Y
    Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Int J Oncol. 2017;50:448-456.
    >> Share

    December 2016
  76. LEE JH, Kim SS, Lee HS, Hong S, et al
    Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3793.
    >> Share

    November 2016
  77. LI R, Yang HQ, Xi HL, Feng S, et al
    Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
    Int J Oncol. 2016 Nov 28. doi: 10.3892/ijo.2016.3783.
    >> Share

    October 2016
  78. XU M, Zhou H, Zhang C, He J, et al
    ADAM17 promotes epithelial-mesenchymal transition via TGF-beta/Smad pathway in gastric carcinoma cells.
    Int J Oncol. 2016 Oct 21. doi: 10.3892/ijo.2016.3744.
    >> Share

    September 2016
  79. HUANG T, Wang-Johanning F, Zhou F, Kallon H, et al
    MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review).
    Int J Oncol. 2016 Sep 9. doi: 10.3892/ijo.2016.3686.
    >> Share

    August 2016
  80. TANG C, Jiang Y, Shao W, Shi W, et al
    Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3661.
    >> Share

  81. XIE P, Fujii I, Zhao J, Shinohara M, et al
    A novel polysaccharide derived from algae extract induces apoptosis and cell cycle arrest in human gastric carcinoma MKN45 cells via ROS/JNK signaling pathway.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3658.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016